Drug Type Small molecule drug |
Synonyms ZYBK 2 |
Target |
Mechanism HLA-DRB1 inhibitors(major histocompatibility complex, class II, DR beta 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Rheumatoid Arthritis | Phase 1 | IN | 08 Aug 2020 |